Source: Oncotarget. Unidade: FM
Subjects: PULMÃO, NEOPLASIAS PLEURAIS, MODELOS ANIMAIS, EXPRESSÃO GÊNICA
ABNT
ACENCIO, Milena Marques Pagliarelli et al. Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion. Oncotarget, v. 8, n. 62, p. 105093-105102, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.21362. Acesso em: 14 nov. 2024.APA
Acencio, M. M. P., Acencio, M. M. P., Puka, J., Alvarenga, V. A., Martins, V., Carvalho, M. L. P. de, et al. (2017). Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion. Oncotarget, 8( 62), 105093-105102. doi:10.18632/oncotarget.21362NLM
Acencio MMP, Acencio MMP, Puka J, Alvarenga VA, Martins V, Carvalho MLP de, Marchi E, Capelozzi VL, Teixeira LR. Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion [Internet]. Oncotarget. 2017 ; 8( 62): 105093-105102.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.21362Vancouver
Acencio MMP, Acencio MMP, Puka J, Alvarenga VA, Martins V, Carvalho MLP de, Marchi E, Capelozzi VL, Teixeira LR. Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion [Internet]. Oncotarget. 2017 ; 8( 62): 105093-105102.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.21362